[go: up one dir, main page]

NO20062666L - Anvendelse av desoksypeganin for behandling av schizofrene psykoser - Google Patents

Anvendelse av desoksypeganin for behandling av schizofrene psykoser

Info

Publication number
NO20062666L
NO20062666L NO20062666A NO20062666A NO20062666L NO 20062666 L NO20062666 L NO 20062666L NO 20062666 A NO20062666 A NO 20062666A NO 20062666 A NO20062666 A NO 20062666A NO 20062666 L NO20062666 L NO 20062666L
Authority
NO
Norway
Prior art keywords
deoxypeganine
treatment
schizophrenic psychoses
schizophrenic
psychoses
Prior art date
Application number
NO20062666A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Opitz
Joachim Moormann
Hilke Winterhoff
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34625212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062666(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20062666L publication Critical patent/NO20062666L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20062666A 2003-11-24 2006-06-09 Anvendelse av desoksypeganin for behandling av schizofrene psykoser NO20062666L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10354893A DE10354893B4 (de) 2003-11-24 2003-11-24 Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
PCT/EP2004/012605 WO2005053673A1 (fr) 2003-11-24 2004-11-08 Utilisation de desoxypeganine pour traiter des psychoses schizophrenes

Publications (1)

Publication Number Publication Date
NO20062666L true NO20062666L (no) 2006-06-09

Family

ID=34625212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062666A NO20062666L (no) 2003-11-24 2006-06-09 Anvendelse av desoksypeganin for behandling av schizofrene psykoser

Country Status (23)

Country Link
US (1) US20070072947A1 (fr)
EP (1) EP1725229B1 (fr)
JP (1) JP2007512269A (fr)
KR (1) KR20070085036A (fr)
CN (1) CN1886127A (fr)
AR (1) AR046664A1 (fr)
AT (1) ATE424197T1 (fr)
AU (1) AU2004294689B2 (fr)
BR (1) BRPI0416411A (fr)
CA (1) CA2547171A1 (fr)
DE (2) DE10354893B4 (fr)
DK (1) DK1725229T3 (fr)
EA (1) EA012033B1 (fr)
ES (1) ES2323645T3 (fr)
IL (1) IL175772A0 (fr)
MY (1) MY141730A (fr)
NO (1) NO20062666L (fr)
NZ (1) NZ547103A (fr)
SI (1) SI1725229T1 (fr)
TW (1) TW200607507A (fr)
UA (1) UA86951C2 (fr)
WO (1) WO2005053673A1 (fr)
ZA (1) ZA200603543B (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE10119863A1 (de) * 2001-04-24 2002-11-07 Hf Arzneimittelforsch Gmbh Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
DE10163667B4 (de) * 2001-12-21 2006-10-26 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung der klinischen Depression

Also Published As

Publication number Publication date
DE502004009105D1 (de) 2009-04-16
ES2323645T3 (es) 2009-07-22
KR20070085036A (ko) 2007-08-27
DK1725229T3 (da) 2009-06-22
NZ547103A (en) 2009-07-31
JP2007512269A (ja) 2007-05-17
EP1725229B1 (fr) 2009-03-04
UA86951C2 (ru) 2009-06-10
US20070072947A1 (en) 2007-03-29
ATE424197T1 (de) 2009-03-15
AU2004294689B2 (en) 2010-01-07
CN1886127A (zh) 2006-12-27
AR046664A1 (es) 2005-12-14
IL175772A0 (en) 2008-04-13
EA200601016A1 (ru) 2006-10-27
EP1725229A1 (fr) 2006-11-29
ZA200603543B (en) 2007-03-28
CA2547171A1 (fr) 2005-06-16
SI1725229T1 (sl) 2009-08-31
WO2005053673A1 (fr) 2005-06-16
DE10354893A1 (de) 2005-06-30
AU2004294689A1 (en) 2005-06-16
EA012033B1 (ru) 2009-06-30
HK1093696A1 (zh) 2007-03-09
DE10354893B4 (de) 2011-03-10
TW200607507A (en) 2006-03-01
BRPI0416411A (pt) 2007-01-09
MY141730A (en) 2010-06-15

Similar Documents

Publication Publication Date Title
TW200505881A (en) Tri(cyclo) substituted amide compounds
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
AU2009303758A8 (en) Benzoquinoline inhibitors of vesicular monoamine transporter 2
UA87865C2 (en) Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof, and use thereof as medicaments
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20082496L (no) Pyrazinderivater
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
TW200606162A (en) Pyrazolopyridine derivatives
DE60334536D1 (de) Furylverbindungen
DE502004005033D1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
MXPA05012247A (es) Derivados de bencimidazol nuevos.
NO20072005L (no) Nye heterocykliske amider
NO20073839L (no) Kinolinderivat, fremgangsmate for fremstilling og anvendelse av dette, og legemiddel inneholdende dette
DE602004006869D1 (de) 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit
SE0300850D0 (sv) Chemical compounds
SE0200844D0 (sv) Chemical compounds
CY1112638T1 (el) Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
UA96277C2 (en) Benzimidazole derivatives
UA88481C2 (ru) Донепезила фумарат, пригодный для получения фармацевтических композиций
SE0401763D0 (sv) Compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application